Association between Stenotrophomonas maltophilia and lung function in cystic fibrosis

Thorax

Volumn 59, Issue 11, 2004, Pages 955-959

  Goss, C H ^a   Mayer Hamblett, N ^a   Aitken, M L ^a   Rubenfeld, G D ^a   Ramsey, B W ^a  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL COLONIZATION; BODY HEIGHT; BURKHOLDERIA CEPACIA; COHORT ANALYSIS; CYSTIC FIBROSIS; CYSTIC FOUNDATION NATIONAL PATIENT REGISTRY; DISEASE ASSOCIATION; FEMALE; FORCED EXPIRATORY VOLUME; GENDER; HOSPITAL ADMISSION; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; NON PROFIT ORGANIZATION; PANCREAS INSUFFICIENCY; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; REGISTER; STENOTROPHOMONAS MALTOPHILIA;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; CYSTIC FIBROSIS; FEMALE; FORCED EXPIRATORY VOLUME; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; INFANT; MALE; STENOTROPHOMONAS MALTOPHILIA;

EID: 8544272497     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.2003.017707     Document Type: Article

References (19)

1. Rosenstein BJ, Cutting GR. The diagnosis of cystic fibrosis: a consensus statement. Cystic Fibrosis Foundation Consensus Panel. J Pediatr 1998;132:589-95.
2. Cystic Fibrosis Foundation. Patient registry 2000 annual data report. Bethesda, MD: Cystic Fibrosis Foundation, 2001:1-2.
3. Tablan OC, Chorba TL, Schidlow DV, et al. Pseudomonas cepacia colonization in patients with cystic fibrosis: risk factors and clinical outcome. J Pediatr 1985;107:382-7.
4. Rajan S, Saiman L. Pulmonary infections in patients with cystic fibrosis. Semin Respir Infect 2002;17:47-56.
5. Denton M, Kerr KG. Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia. Clin Microbiol Rev 1998;11:57-80.
6. Gladman G, Connor PJ, Williams RF, et al. Controlled study of Pseudomonas cepacia and Pseudomonas maltophilia in cystic fibrosis. Arch Dis Child 1992;67:192-5.
7. Karpati F, Malmborg AS, Alfredsson H, et al. Bacterial colonisation with Xanthomonas maltophilia: a retrospective study in a cystic fibrosis patient population. Infection 1994;22:258-63.
8. Demko CA, Stern RC, Doershuk CF. Stenotrophomonas maltophilia in cystic fibrosis: incidence and prevalence. Pediatr Pulmonol 1998;25:304-8.
9. Goss CH, Otto K, Aitken ML, et al. Detecting Stenotrophomonas maltophilia does not reduce survival of patients with cystic fibrosis. Am J Respir Crit Care Med 2002;166:356-61.
10. Fitzsimmons SC. The changing epidemiology of cystic fibrosis. J Pediatr 1993;122:1-9.
11. Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika 1986;73:13-22.
12. Bauernfeind A, Emminger G, Horl G, et al. Bacteriological effects of anti-Pseudomonas aeruginosa chemotherapy in cystic fibrosis. Infection 1987;15:403-6.
13. Denton M, Todd NJ, Littlewood JM. Role of anti-pseudomonal antibiotics in the emergence of Stenotrophomonas maltophilia in cystic fibrosis patients. Eur J Clin Microbiol Infect Dis 1996;15:402-5.
14. Burns JL, Emerson J, Stapp JR, et al. Microbiology of sputum from patients at cystic fibrosis centers in the United States. Clin Infect Dis 1998;27:158-63.
15. Shreve MR, Butler S, Kaplowitz HJ, et al. Impact of microbiology practice on cumulative prevalence of respiratory tract bacteria in patients with cystic fibrosis. J Clin Microbiol 1999;37:753-7.
16. Cystic Fibrosis Foundation. Microbiology and infectious disease in cystic fibrosis. Concepts of care. Rockville, MD: Cystic Fibrosis Foundation, 1994:1-26.
17. Krzewinski JW, Nguyen CD, Foster JM, et al. Use of random amplified polymorphic DNA PCR to examine the epidemiology of Stenotrophomonas maltophilia and Achromobacter (Alcaligenes) xylosoxidans from patients with cystic fibrosis. J Clin Microbiol 2001;39:3597-602.
18. Graff GR, Burns JL. Factors affecting the incidence of Stenotrophomonas maltophilia isolation in cystic fibrosis. Chest 2002;121:1754-60.
19. Talmaciu I, Vorlotta L, Mortensen J, et al. Risk factors for emergence of Stenotrophomonas maltophilia in cystic fibrosis. Pediatr Pulmonol 2000;30:10-5.